These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8670807)

  • 21. Cloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expression.
    Tavtigian SV; Zabludoff SD; Wold BJ
    Mol Biol Cell; 1994 Mar; 5(3):375-88. PubMed ID: 8049528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-specific responses to loss of cyclin-dependent kinases.
    Berthet C; Kaldis P
    Oncogene; 2007 Jul; 26(31):4469-77. PubMed ID: 17297466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a p53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519.
    Pourbagheri-Sigaroodi A; Safaroghli-Azar A; Shanaki M; Yousefi AM; Anjam Najmedini A; Bashash D
    Iran J Pharm Res; 2020; 19(3):144-155. PubMed ID: 33680018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morusin inhibits cell proliferation and tumor growth by down-regulating c-Myc in human gastric cancer.
    Wang F; Zhang D; Mao J; Ke XX; Zhang R; Yin C; Gao N; Cui H
    Oncotarget; 2017 Aug; 8(34):57187-57200. PubMed ID: 28915664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin dependent protein kinases and stress responses in plants.
    Kitsios G; Doonan JH
    Plant Signal Behav; 2011 Feb; 6(2):204-9. PubMed ID: 21512322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myc-induced cyclin D2 genomic instability in murine B cell neoplasms.
    Mushinski JF; Hanley-Hyde J; Rainey GJ; Kuschak TI; Taylor C; Fluri M; Stevens LM; Henderson DW; Mai S
    Curr Top Microbiol Immunol; 1999; 246():183-9; discussion 190-2. PubMed ID: 10396055
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclin-dependent kinases-based synthetic lethality: Evidence, concept, and strategy.
    Li K; You J; Wu Q; Meng W; He Q; Yang B; Zhu C; Cao J
    Acta Pharm Sin B; 2021 Sep; 11(9):2738-2748. PubMed ID: 34589394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myc and a Cdk2 senescence switch.
    van Riggelen J; Felsher DW
    Nat Cell Biol; 2010 Jan; 12(1):7-9. PubMed ID: 20027199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical inhibitors of cyclin-dependent kinases.
    Meijer L
    Trends Cell Biol; 1996 Oct; 6(10):393-7. PubMed ID: 15157522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction: Combined Depletion of Cell Cycle and Transcriptional Cyclin-Dependent Kinase Activities Induces Apoptosis in Cancer Cells.
    Cai D; Latham VM; Zhang X; Shapiro GI
    Cancer Res; 2020 Jan; 80(2):361. PubMed ID: 31941678
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclin-Dependent Kinase Inhibitors Induce Apoptosis in Plant Cells.
    Strnad M; Havlia L; Binarova P; Kryscaron V; Hanuscaron J; Siglerova V; Boumlgre L; Heberle-Bors E
    ScientificWorldJournal; 2001; 1():126. PubMed ID: 30147605
    [No Abstract]   [Full Text] [Related]  

  • 32. An intergenic regulatory region mediates Drosophila Myc-induced apoptosis and blocks tissue hyperplasia.
    Zhang C; Casas-Tintó S; Li G; Lin N; Chung M; Moreno E; Moberg KH; Zhou L
    Oncogene; 2015 Apr; 34(18):2412. PubMed ID: 25924716
    [No Abstract]   [Full Text] [Related]  

  • 33. Correction: Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies.
    Cancer Res; 2017 Dec; 77(23):6789. PubMed ID: 29196417
    [No Abstract]   [Full Text] [Related]  

  • 34. Wnt Signaling Pathway Collapse upon β-Catenin Destruction by a Novel Antimicrobial Peptide SKACP003: Unveiling the Molecular Mechanism and Genetic Activities Using Breast Cancer Cell Lines.
    Selvarathinam K; Subramani P; Thekkumalai M; Vilwanathan R; Selvarajan R; Abia ALK
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy.
    Dantonio PM; Klein MO; Freire MRVB; Araujo CN; Chiacetti AC; Correa RG
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30166456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The T-Box factor TBX3 is important in S-phase and is regulated by c-Myc and cyclin A-CDK2.
    Willmer T; Peres J; Mowla S; Abrahams A; Prince S
    Cell Cycle; 2015; 14(19):3173-83. PubMed ID: 26266831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated cyclin A associated kinase activity promotes sensitivity of metastatic human cancer cells to DNA antimetabolite drug.
    Wang J; Yin H; Panandikar A; Gandhi V; Sen S
    Int J Oncol; 2015 Aug; 47(2):782-90. PubMed ID: 26058363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WNT signaling: an emerging mediator of cancer cell metabolism?
    Sherwood V
    Mol Cell Biol; 2015 Jan; 35(1):2-10. PubMed ID: 25348713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.
    Diolaiti D; McFerrin L; Carroll PA; Eisenman RN
    Biochim Biophys Acta; 2015 May; 1849(5):484-500. PubMed ID: 24857747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MYC-y mice: from tumour initiation to therapeutic targeting of endogenous MYC.
    Morton JP; Sansom OJ
    Mol Oncol; 2013 Apr; 7(2):248-58. PubMed ID: 23523308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.